Subtractive transcriptomics: establishing polarity drives in vitro human endothelial morphogenesis.
Although investigations of mature normal and tumor-derived capillaries have resulted in characterization of these structures at the phenotypic level, less is known regarding the initial molecular cues for cellular assembly of endothelial cells into human capillaries. Here, we employ a novel combination of microenvironmental manipulation and microarray data filtration over narrowly delineated temporal data series to identify the morphogenesis component apart from the proliferation component, as pooled human microvascular-derived endothelial cells are induced to form capillary-like structures in vitro in a murine tumor-derived matrix. The 217 morphogenesis-specific genes identified using this subtractive transcriptomics approach are mostly independent of the angiogenic proteins currently used as therapeutic targets for aberrant angiogenesis. Quantitative real-time PCR was used to validate 20% of these transcripts. Immunofluorescent analysis of proliferating and tube-forming cells validates at the protein level the morphogenesis-specific expression pattern of 16 of the 217 gene products identified. The transcripts that are selectively up-regulated in tube-forming endothelial cells reveal a temporal expression pattern of genes primarily associated with intracellular trafficking, guided migration, cytoskeletal reorganization, cellular adhesion, and proliferation inhibition. These data show that a sequential up-regulation of genes that establish and maintain polarity occurs during migration and morphogenesis of in vitro human endothelial cells undergoing tubulogenesis; some of which may well be effective as novel antiangiogenic drug targets.
Glesne
David A
DA
Biosciences Division, Argonne National Laboratory, Argonne, Illinois 60439, USA.
Zhang
Wen
W
Mandava
Suneeta
S
Ursos
Lyann
L
Buell
Margaret E
ME
Makowski
Lee
L
Rodi
Diane J
DJ
D048708:Cell Growth Processes / Q000502:physiology; D002478:Cells, Cultured; D003094:Collagen; D004338:Drug Combinations; D042783:Endothelial Cells / Q000166:cytology / Q000378:metabolism / Q000502:physiology*; D020869:Gene Expression Profiling; D006801:Humans; D007797:Laminin; D009389:Neovascularization, Pathologic / Q000235:genetics / Q000473:pathology; D018919:Neovascularization, Physiologic / Q000235:genetics / Q000502:physiology; D020411:Oligonucleotide Array Sequence Analysis; D011509:Proteoglycans; D014158:Transcription, Genetic
D004338:Drug Combinations; D007797:Laminin; D011509:Proteoglycans; C059485:matrigel; D003094:Collagen